Fmoc-L-aspartic acid β-benzyl ester is a protected L-aspartic acid derivative in which the α-amino group is masked with an Fmoc carbamate and the side-chain carboxyl group is esterified as a β-benzyl ester. The molecule contains an Fmoc-protected amine and two carboxyl-derived functionalities, with the α-carboxyl present as a free acid and the β-carboxyl converted to a benzyl ester, while the stereocenter at the α-carbon is specified as L. In peptide synthesis workflows, it functions as a stepwise-building amino acid building block where the Fmoc group controls chemoselectivity during coupling and the benzyl ester serves as a removable side-chain protecting group for aspartate-containing peptide or peptide-derivative preparation.
CAT No: CP00422
CAS No:86060-84-6
Synonyms/Alias:Fmoc-Asp(OBzl)-OH;86060-84-6;Fmoc-L-asparticacid4-benzylester;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(benzyloxy)-4-oxobutanoicacid;L-Fmoc-asparticacidbeta-benzylester;ST51016063;(2S)-4-(benzyloxy)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-4-oxobutanoicacid;L-Fmoc-asparticacidbelta-benzylester;4-BenzylN-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-aspartate;fmoc-l-asp(obzl)-oh;PubChem10005;KSC496E9F;4-BenzylN-Fmoc-L-aspartate;47593_ALDRICH;SCHEMBL119962;47593_FLUKA;CTK3J6292;MolPort-002-497-242;ACT08950;ZINC2539219;Fmoc-L-asparticacidb-benzylester;ANW-74484;CF-173;AKOS015895331;AKOS015922806
Fmoc-L-aspartic acid β-benzyl ester is an Fmoc-protected L-aspartate derivative in which the α-amino group is masked as an N-(9H-fluorenylmethoxycarbonyl) carbamate and the side-chain carboxyl is esterified with a benzyl group at the β-position. The molecule contains a stereogenic center at the α-carbon (L-configuration) and presents two carboxyl-derived functional handles: an Fmoc-protected amine for controlled peptide coupling and a benzyl-protected β-carboxyl for orthogonal side-chain chemistry. The benzyl ester is stable under many base-mediated steps used in solid-phase peptide synthesis while remaining amenable to hydrogenolysis, enabling selective side-chain deprotection and subsequent transformation. The combination of an acid-bearing side chain protected as a benzyl ester and a base-labile Fmoc group supports predictable deprotection logic and downstream conversion into aspartyl residues, aspartate analogs, and functionalized peptide building blocks.
1. Peptide Synthesis
Fmoc-L-aspartic acid β-benzyl ester is used in peptide building block preparation for automated and manual peptide assembly where orthogonal protection is required for aspartate side-chain chemistry. The Fmoc carbamate enables standard N-terminal deprotection to generate a reactive amine for peptide coupling, while the β-benzyl ester protects the side-chain carboxyl from undesired acylation or salt formation during chain elongation. The L-aspartate stereochemistry supports incorporation of the correct chiral center into peptide sequences, including Asp-containing motifs used for charge patterning and backbone recognition. Downstream cleavage of the benzyl ester can furnish free aspartate side chains for generating peptides that require anionic functionality or for enabling further side-chain derivatization prior to final deprotection.
2. Side-Chain Functionalization
Fmoc-L-aspartic acid β-benzyl ester is applied to side-chain functionalization workflows that convert the β-carboxyl handle into protected or activated derivatives for subsequent molecular modification. The β-benzyl ester provides a chemically distinct protection state relative to the Fmoc group, supporting stepwise strategies in which N-terminal unmasking and side-chain transformation can be scheduled independently. The protected β-carboxyl can be selectively deprotected to yield an aspartate carboxylate for coupling to amines, alcohols, or heteroatom nucleophiles, enabling generation of peptide conjugates, ester/amide variants, or activated intermediates for further synthetic elaboration. The resulting aspartate-functionalized products can be used to tune polarity, hydrogen-bonding patterns, and local electrostatics in peptide scaffolds and peptidomimetic structures.
3. Unnatural Amino Acid Incorporation
Fmoc-L-aspartic acid β-benzyl ester serves as a chiral amino acid intermediate for constructing aspartate-based analogs in chemical biology and SAR studies where controlled stereochemistry and protected functional groups are required. The Fmoc-protected amine and β-benzyl ester together allow the compound to be handled as a stable, isolable chiral unit that can be incorporated into peptide-like frameworks while deferring side-chain exposure until the desired stage. The orthogonal deprotection pattern supports synthesis of Asp-containing unnatural sequences, including variants that undergo post-assembly side-chain modification to generate charge-neutral or charge-altered analogs. The chiral center and protected carboxyl arrangement make it suitable for preparing defined stereochemical intermediates that can be carried into downstream coupling, conjugation, or fragment assembly steps.
4. Chemical Manufacturing
Fmoc-L-aspartic acid β-benzyl ester can be employed in process chemistry and fine chemical synthesis as a protected aspartate feedstock for producing Fmoc-based peptide building blocks at scale. The molecule's protection scheme aligns with manufacturing workflows that require predictable handling under base conditions used for Fmoc deprotection while maintaining side-chain protection during intermediate storage and purification. The benzyl ester provides a robust protecting-group strategy that can be removed selectively in later stages, supporting manufacturing routes that generate free aspartate functionality for subsequent derivatization steps. The compound's defined stereochemistry and functional-group compatibility support consistent intermediate preparation for industrial peptide manufacturing, including generation of aspartyl residues and aspartate-containing intermediates for downstream specialty chemical production.
5. Analytical Research Standards
Fmoc-L-aspartic acid β-benzyl ester is suitable for analytical research and method development where defined protected amino acid standards are needed to monitor peptide synthesis steps and protecting-group behavior. The presence of both Fmoc and a benzyl ester creates characteristic chromatographic and spectroscopic signatures that can be used to track deprotection, coupling completion, and side-chain protection integrity in complex reaction mixtures. The L-aspartate stereochemical identity supports use as a reference material for stereochemically consistent comparisons when evaluating derivatization outcomes or impurity profiles. The compound can also function as a chemically defined intermediate for generating labeled or derivatized aspartate standards used in quality control of peptide building block preparation and downstream peptide analog construction.
3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
5. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.